Design and conduct of confirmatory chronic pain clinical trials

被引:20
作者
Katz, Nathaniel [1 ]
机构
[1] WCG Analges Solut, 321 Commonwealth Rd,Suite 204, Wayland, MA 01778 USA
关键词
Chronic pain; Clinical trial design and conduct; Measurement error; Confirmatory trials; RANDOMIZED CONTROLLED-TRIALS; PERIPHERAL NEUROPATHIC PAIN; CAPSAICIN 8-PERCENT PATCH; STATISTICAL PROCESS-CONTROL; CONTROLLED CROSSOVER TRIAL; PLACEBO-CONTROLLED TRIALS; EMERGING GOOD PRACTICES; LOW-BACK-PAIN; DOUBLE-BLIND; POSTHERPETIC NEURALGIA;
D O I
10.1097/PR9.0000000000000854
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The purpose of this article is to provide readers with a basis for understanding the emerging science of clinical trials and to provide a set of practical, evidence-based suggestions for designing and executing confirmatory clinical trials in a manner that minimizes measurement error. The most important step in creating a mindset of quality clinical research is to abandon the antiquated concept that clinical trials are a method for capturing data from clinical practice and shifting to a concept of the clinical trial as a measurement system, consisting of an interconnected set of processes, each of which must be in calibration for the trial to generate an accurate and reliable estimate of the efficacy (and safety) of a given treatment. The status quo of inaccurate, unreliable, and protracted clinical trials is unacceptable and unsustainable. This article gathers aspects of study design and conduct under a single broad umbrella of techniques available to improve the accuracy and reliability of confirmatory clinical trials across traditional domain boundaries.
引用
收藏
页数:35
相关论文
共 269 条
[1]   Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee A Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Study [J].
Afilalo, Marc ;
Etropolski, Mila S. ;
Kuperwasser, Brigitte ;
Kelly, Kathy ;
Okamoto, Akiko ;
Van Hove, Ilse ;
Steup, Achim ;
Lange, Bernd ;
Rauschkolb, Christine ;
Haeussler, Juergen .
CLINICAL DRUG INVESTIGATION, 2010, 30 (08) :489-505
[2]   Genetic Testing for Opioid Pain Management: A Primer [J].
Agarwal, Deepti ;
Udoji, Mercy A. ;
Trescot, Andrea .
PAIN AND THERAPY, 2017, 6 (01) :93-105
[3]   Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study [J].
Altman, Roy ;
Hochberg, Marc ;
Gibofsky, Allan ;
Jaros, Mark ;
Young, Clarence .
CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (12) :2331-2343
[4]   A Bayesian Perspective on Sensory and Cognitive Integration in Pain Perception and Placebo Analgesia [J].
Anchisi, Davide ;
Zanon, Marco .
PLOS ONE, 2015, 10 (02)
[5]   Impact of source data verification on data quality in clinical trials: an empirical post hoc analysis of three phase 3 randomized clinical trials [J].
Andersen, Jeppe Ragnar ;
Byrjalsen, Inger ;
Bihlet, Asger ;
Kalakou, Faidra ;
Hoeck, Hans Christian ;
Hansen, Gitte ;
Hansen, Henrik Bo ;
Karsdal, Morten Asser ;
Riis, Bente Juel .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (04) :660-668
[6]   Physical symptoms distress index - A sensitive tool to evaluate the impact of pharmacological agents on quality of life [J].
Anderson, RB ;
Hollenberg, NK ;
Williams, GH .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (07) :693-700
[7]  
[Anonymous], 1991, The design of analgesic clinical trials: advances in pain research and therapy
[8]  
[Anonymous], 1931, EC CONTROL QUALITY M
[9]  
[Anonymous], 1994, Accuracy trueness and precision of measurement methods and results
[10]  
[Anonymous], 1997, MONITOR, P15